NSAID Hope for Postmenopausal Breast Cancer Recurrence Risk Reduction

Obese women at risk of postmenopausal breast cancer recurrence may benefit from COX-2 inhibition...

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.